GlaxoSmithKline

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Greenphire

Greenphire is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS payment solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The company’s newest product, ConneX, is the most personalized clinical trial travel solution designed specifically to meet the recruitment and retention goals of domestic and international clinical trials.

The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Advarra

Schulman IRB and Chesapeake IRB have merged to create Advarra, the premier provider of IRB, IBC and global research compliance services. By integrating our innovative technology and proven regulatory expertise, Advarra helps ensure the highest standards of human research protections. Advarra supports all research phases across all major therapeutic areas.